The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what would you do for somebody with high lp little a we have strategies which is mostly attacking april b right now and any other cardiovascular risk factor but there are drugs in the pipeline that may give us better alternatives to perhaps stop
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i think one of the reason that people are reluctant to measure lpa is that because there's no treatment for for high lpa